California BanCorp (BCAL) files Form 144 to sell 6,300 shares valued at $105,239
Rhea-AI Filing Summary
California BanCorp (BCAL) filed a Form 144 notifying the proposed sale of 6,300 common shares through Wells Fargo Clearing Services on NASDAQ with an aggregate market value of $105,239.08. The shares were acquired on 03/01/2023 as compensation from the issuer and were paid in full on that date. The filing lists 32,517,595 shares outstanding for the class. The filer also disclosed a related sale in the past three months: 7,000 shares sold on 06/13/2025 by the David and Anne Ranier Trust for gross proceeds of $102,449.15. The notice includes the signer’s representation that no undisclosed material adverse information is known.
Positive
- Transparent disclosure of proposed sale including broker, exchange, and aggregate market value
- Acquisition source clearly stated as compensation from the issuer, with acquisition and payment dates provided
- Related recent sale in the past three months is disclosed (7,000 shares on 06/13/2025) which improves transparency
Negative
- Insider/affiliate selling is occurring (proposed 6,300-share sale and a recent 7,000-share sale), which may be viewed unfavorably by some investors
Insights
TL;DR: Routine insider/affiliate sale notification; small absolute size relative to market cap, appears procedural.
The Form 144 documents a proposed sale of 6,300 common shares acquired as compensation on 03/01/2023, routed through a major broker and listed for sale on NASDAQ with an aggregate value of $105,239.08. The filing provides transparency about recent related activity, including a 7,000-share sale on 06/13/2025 generating $102,449.15. From an investor disclosure perspective, this is a standard compliance filing that notifies the market of potential insider/affiliate selling. There is no operational, earnings, or credit information in the filing to suggest company-level material change.
TL;DR: Compliance documentation appears complete; includes required provenance and recent sales history.
The form provides required acquisition details (date, nature as compensation, issuer as source) and settlement/payment information, along with a past three-month sale record and the broker handling the proposed sale. The signer affirms no undisclosed material adverse information. For regulatory and disclosure risk assessment, the filing meets Rule 144 notice elements; it does not allege any exculpatory or atypical payment arrangements. No material compliance concerns are evident from the data presented.